In our current study, CTC-positive rates were not significantly associated with gender, age, differentiation, tumor position, tumor size, invasion depth, lymph node metastasis, distant metastasis, TNM stage, and CEA and CA199 levels. The gene discussed is CEACAM5; the disease is neoplasm.